NCT02631746
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02631746
Title Nivolumab in Treating Patients With HTLV-Associated T-Cell Leukemia/Lymphoma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore Maryland 21287 United States Details
National Institutes of Health Clinical Center Bethesda Maryland 20892 United States Details
NCI - Center for Cancer Research Bethesda Maryland 20892 United States Details
Montefiore Medical Center-Einstein Campus The Bronx New York 10461 United States Details
Montefiore Medical Center - Moses Campus The Bronx New York 10467 United States Details
Ohio State University Comprehensive Cancer Center Columbus Ohio 43210 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field